An exploratory study the Food and Drug Administration is funding about what US consumers kratom users know about the botanical appears to some as an attempt to gather information to support a conclusion the agency’s already reached.
“It appears FDA is endeavoring to lay a foundation for renewed argument to schedule kratom as a controlled substance or...
Welcome to HBW Insight
Create an account to read this article
Already a subscriber?